Filing Flows › BridgeBio Pharma (BBIO) › Net product revenue revenue
BridgeBio Pharma (BBIO) Net product revenue revenue by quarter
BridgeBio Pharma's Net product revenue revenue was $253M in Q3 2026 (third quarter 2026), +14% from Q2 2026. Over the last 5 quarters it ranged from $108M (Q3 2025) to $253M (Q3 2026).
| Quarter | Net product revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $253M | +14% | +134% |
| Q2 2026 | $222M | +23% | — |
| Q1 2026 | $181M | +24% | — |
| Q4 2025 | $146M | +35% | — |
| Q3 2025 | $108M | — | — |
Q3 2026 at a glance
BridgeBio Pharma, Q3 2026: revenue $353M (+193% year over year), operating margin -3.3%, net loss $60.5M, operating cash flow −$44.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is BridgeBio Pharma's Net product revenue revenue?
BridgeBio Pharma's Net product revenue revenue was $253M in Q3 2026 (third quarter 2026), +14% from Q2 2026.
How has BridgeBio Pharma's Net product revenue revenue changed?
Over the last 5 quarters it ranged from $108M (Q3 2025) to $253M (Q3 2026).